Analysis of relapse rates and risk factors of tapering or stopping pharmacologic therapies in axial spondyloarthritis patients with sustained remission-Reference-Cited by-同舟云学术

Analysis of relapse rates and risk factors of tapering or stopping pharmacologic therapies in axial spondyloarthritis patients with sustained remission

Published:2018-04-18 Issue:6 Volume:37 Page:1625-1632
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Chen Xiaochan,Zhang Ting,Wang Wenwen,Xue Jing

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/article/10.1007/s10067-018-4084-4/fulltext.html

Reference19 articles.

1. Poddubnyy D, Gensler LS (2014) Spontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis. Best Pract Res Clin Rheumatol 28(5):807–818. https://doi.org/10.1016/j.berh.2014.10.005

2. Zochling J, Bohl-Buhler MH, Baraliakos X, Feldtkeller E, Braun J (2006) Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis—a population-based survey. Clin Rheumatol 25(6):794–800. https://doi.org/10.1007/s10067-005-0132-y

3. Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Marker-Hermann E, Zeidler H, Braun J, Sieper J (2012) Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 71(10):1616–1622. https://doi.org/10.1136/annrheumdis-2011-201252

4. Sieper J, Listing J, Poddubnyy D, Song IH, Hermann KG, Callhoff J, Syrbe U, Braun J, Rudwaleit M (2016) Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS). Ann Rheum Dis 75(8):1438–1443. https://doi.org/10.1136/annrheumdis-2015-207897

5. Navarro-Compan V, Plasencia-Rodriguez C, de Miguel E, Balsa A, Martin-Mola E, Seoane-Mato D, Canete JD (2016) Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: a systematic literature review. Rheumatology 55(7):1188–1194. https://doi.org/10.1093/rheumatology/kew033

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis;Nature Reviews Rheumatology;2023-10-06

2. Patient-tailored dose reduction of tumor necrosis factor inhibitors in axial spondyloarthritis;International Immunopharmacology;2023-03

3. Tapering biologics in axial spondyloarthritis: A systematic literature review;International Immunopharmacology;2022-11

4. Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial;Annals of the Rheumatic Diseases;2022-06-14

5. Is tapering or discontinuation of biologic treatment in patients with radiographic and nonradiographic axial spondyloarthritis reasonable?;Zeitschrift für Rheumatologie;2022-06-07